Neuboron Medical Group
PrivateLast Round
Strategic
Dec 9, 2020
Total Funding Raised
$10M
Company Overview
Neuboron Medical Group is a medical technology company that provides comprehensive Boron Neutron Capture Therapy (BNCT) solutions, including accelerator-based BNCT systems, treatment planning software, and targeted boron drugs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuboron Medical Group Comparables
Compare Neuboron Medical Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dawon Medax | 87% | |
| Neutron Therapeutics | 87% | |
| Resorttrust, Inc. | 79% | |
Neuboron Medical Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 9, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 563% MoM.
Neuboron Medical Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuboron Medical Group's valuation, stock price, and market status.